GO:0016805 dipeptidase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016805 dipeptidase activity is defined as the catalysis of the hydrolysis of a dipeptide, a fundamental molecular function in protein catabolism and peptide recycling.
• Dipeptidases are metalloenzymes or cysteine-dependent hydrolases that cleave the peptide bond between two amino acids, often with metal cofactors such as zinc or manganese.
• Key enzymes include CNDP1 (carnosine dipeptidase 1), CNDP2 (carnosine dipeptidase 2), PEPD (prolidase), and DPEP1 (renal dipeptidase), each with distinct substrate specificities and tissue distributions.
• Dipeptidase activity is critical for the metabolism of carnosine, glutathione recycling, and the final steps of protein digestion in the small intestine.
• Dysregulation of dipeptidase activity is linked to neurological disorders, cancer, and metabolic diseases, making these enzymes potential therapeutic targets.
• CRISPR-based knockout, point mutation, and overexpression models are essential tools for dissecting the physiological roles of dipeptidases in health and disease.
Description
Dipeptidase activity, formally annotated as GO:0016805, is a molecular function that catalyzes the hydrolysis of a dipeptide into two free amino acids. This activity is essential for the terminal steps of protein digestion, the recycling of dipeptides derived from intracellular proteolysis, and the metabolism of bioactive peptides such as carnosine. Dipeptidases are widely distributed across species, from bacteria to humans, and exhibit diverse substrate specificities and metal cofactor requirements. In humans, dipeptidases such as CNDP1, CNDP2, PEPD, and DPEP1 play critical roles in amino acid homeostasis and detoxification. Understanding the molecular mechanisms and regulation of dipeptidase activity is crucial for elucidating its contributions to physiology and disease. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a comprehensive overview of dipeptidase activity, its key genes, research methods, and relevance to human health.
dipeptidase activity At A Glance
| GO ID | GO:0016805 |
|---|---|
| GO term | dipeptidase activity |
| Ontology | molecular_function |
| Synonym | cytosolic dipeptidase activity |
| Definition | Catalysis of the hydrolysis of a dipeptide. |
| Major function | Hydrolysis of dipeptides into free amino acids |
| Cofactors | Zinc, manganese, or cysteine-dependent mechanisms |
| Representative genes | CNDP1, CNDP2, PEPD, DPEP1, LAP3 |
| Subcellular location | Cytosol, plasma membrane, secreted |
What Is GO:0016805?
According to the Gene Ontology, GO:0016805 dipeptidase activity is defined as the catalysis of the hydrolysis of a dipeptide. A dipeptide is a molecule composed of two amino acids linked by a single peptide bond. This activity cleaves that bond, releasing the two constituent amino acids. The term is classified under molecular_function and includes the synonym cytosolic dipeptidase activity. Dipeptidases are distinct from exopeptidases that act on longer peptides, as they specifically target dipeptides.
Why Is dipeptidase activity Important in Cell Biology?
Dipeptidase activity is fundamental to amino acid metabolism, protein turnover, and the bioavailability of dietary nitrogen. It enables the final breakdown of dipeptides generated by gastric and pancreatic proteases, allowing efficient absorption of amino acids in the small intestine. Beyond digestion, dipeptidases regulate the levels of bioactive peptides such as carnosine, which has antioxidant and anti-glycation properties. They also participate in glutathione recycling by hydrolyzing cysteinylglycine, a key step in maintaining cellular redox balance. Dysregulation of dipeptidase activity has been implicated in neurological disorders, cancer, and metabolic syndromes, underscoring its clinical importance.
• Essential for terminal protein digestion and amino acid absorption in the gut.
• Regulates carnosine homeostasis, affecting antioxidant defense and aging.
• Participates in glutathione recycling via cysteinylglycine hydrolysis.
• Mutations in PEPD cause prolidase deficiency, a rare metabolic disorder.
• Altered expression of CNDP1 and CNDP2 is associated with diabetic nephropathy and cancer.
• Provides targets for antibiotic development, as bacterial dipeptidases are essential for growth.
• Involved in the metabolism of beta-lactam antibiotics by renal dipeptidase.
• Serves as a model for metalloenzyme catalysis and substrate specificity.
• Plays a role in plant glutathione recycling during fruit ripening.
• Enables biotechnological applications such as carnosine synthesis.
Mechanism, Genes and Research Methods of dipeptidase activity
Substrate Recognition and Binding
In simple terms: The enzyme grabs a dipeptide and positions it for cutting.
Dipeptidases recognize their substrates through specific active site pockets that accommodate two amino acid residues. The binding is often mediated by hydrogen bonds and hydrophobic interactions, with metal ions coordinating the substrate's carbonyl oxygen. For example, human renal dipeptidase (DPEP1) binds dipeptides via a dinuclear zinc center, while CNDP2 can utilize either zinc or manganese, affecting substrate specificity. The C69-family cysteine dipeptidase from Lactobacillus farciminis exhibits strong preference for Gly-Pro dipeptides, highlighting the diversity of substrate recognition.
Catalytic Hydrolysis
In simple terms: The enzyme uses water to break the peptide bond.
The hydrolysis of the dipeptide bond proceeds through a nucleophilic attack by a water molecule activated by the active site residues. In metallopeptidases, the metal ion polarizes the water molecule, facilitating attack on the carbonyl carbon. In cysteine dipeptidases, a cysteine residue acts as the nucleophile, forming a covalent intermediate that is subsequently hydrolyzed. The reaction releases the two free amino acids and regenerates the enzyme.
Cofactor Requirements and Metal Dependence
In simple terms: Some dipeptidases need metals like zinc or manganese to work.
Many dipeptidases are metalloenzymes. DPEP1 is a zinc-dependent enzyme, and its activity is inhibited by metal chelators. CNDP2 can bind either zinc or manganese, and the metal form influences substrate specificity; the zinc form has different preferences compared to the manganese form. Immobilized dipeptidase on manganese-loaded nanocrystals has been used for carnosine synthesis, demonstrating the importance of metal cofactors in biocatalysis. In contrast, the C69-family cysteine dipeptidase does not require metal ions.
Subcellular Localization and Tissue Distribution
In simple terms: Dipeptidases are found in different parts of the cell and body.
Dipeptidases are localized in various cellular compartments. CNDP1 and CNDP2 are cytosolic, while DPEP1 is a membrane-bound enzyme expressed in the kidney, intestine, and other tissues. Prolidase (PEPD) is cytosolic and highly expressed in the liver, erythrocytes, and skin. In the small intestinal mucosa, dipeptidase activity is present on the brush border and in the cytosol, contributing to the final stages of protein digestion. Plant dipeptidases, such as the durian leucylaminopeptidase with cysteinylglycine dipeptidase activity, are involved in glutathione recycling during fruit ripening.
Regulation of Dipeptidase Activity
In simple terms: The activity of dipeptidases can be turned up or down.
Dipeptidase activity is regulated at multiple levels. During pregnancy and lactation in rats, dipeptidase activity in the small intestinal mucosa changes, likely due to hormonal influences. The metal form of CNDP2 (zinc vs. manganese) can shift substrate specificity, providing a post-translational regulatory mechanism. In bacteria, expression of dipeptidases is often controlled by nutrient availability and stress responses. Additionally, the activity of prolidase can be modulated by phosphorylation and interactions with other proteins.
Key Genes Involved in GO:0016805 dipeptidase activity
The following genes encode enzymes with dipeptidase activity, each with distinct substrate specificities, tissue distributions, and physiological roles.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CNDP1 | Carnosine dipeptidase 1; hydrolyzes carnosine | Linked to diabetic nephropathy and neurological disorders |
| CNDP2 | Carnosine dipeptidase 2; cytosolic dipeptidase | Metal-dependent substrate specificity; cancer metabolism |
| PEPD | Prolidase; hydrolyzes dipeptides with proline | Prolidase deficiency; wound healing; collagen metabolism |
| DPEP1 | Renal dipeptidase; membrane-bound zinc enzyme | Beta-lactamase activity; cancer biomarker |
| LAP3 | Leucyl aminopeptidase; also has dipeptidase activity | Glutathione recycling; plant ripening |
| C69 family | Cysteine dipeptidase from Lactobacillus | Gly-Pro hydrolysis; bacterial metabolism |
| CN2 | Carnosine dipeptidase 2 (zinc form) | Substrate specificity differences |
| PepD | E. coli prolidase | Model for metalloenzyme studies |
| DPEP1 | Human renal dipeptidase | Antibiotic metabolism |
| CNDP1 | Human carnosine dipeptidase 1 | Carnosine homeostasis |
| CNDP2 | Human carnosine dipeptidase 2 | Cytosolic dipeptidase |
| PEPD | Human prolidase | Proline recycling |
| LAP3 | Durian leucylaminopeptidase | Cysteinylglycine dipeptidase |
| C69 | Lactobacillus farciminis dipeptidase | Gly-Pro hydrolysis |
| DPEP1 | Membrane dipeptidase | Beta-lactam hydrolysis |
| CNDP1 | Carnosine dipeptidase | Antioxidant defense |
| CNDP2 | Carnosine dipeptidase | Manganese/zinc switch |
How Is dipeptidase activity Regulated?
Dipeptidase activity is regulated at transcriptional, post-transcriptional, and post-translational levels. Hormonal changes during pregnancy and lactation alter intestinal dipeptidase activity in rats. Metal cofactor availability modulates the activity and substrate specificity of CNDP2. In bacteria, dipeptidase expression is induced by specific peptides and nutrient limitation. Prolidase activity can be regulated by phosphorylation and protein-protein interactions. Additionally, oxidative stress can affect the activity of cysteine dipeptidases by modifying the active site cysteine.
dipeptidase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PEPD | Prolidase deficiency | Pepd knockout mouse; patient fibroblasts |
| CNDP1 | Diabetic nephropathy | Cndp1 knockout rat; overexpression in podocytes |
| DPEP1 | Cancer (colorectal, renal) | DPEP1 knockout cancer cell lines; xenografts |
| CNDP2 | Cancer metabolism | CNDP2 knockout HeLa cells; metabolic profiling |
| LAP3 | Glutathione recycling | Plant models; Arabidopsis lap3 mutants |
Prolidase Deficiency
Mutations in the PEPD gene cause prolidase deficiency, a rare autosomal recessive disorder characterized by skin ulcers, recurrent infections, and impaired wound healing. Prolidase is essential for recycling proline from dipeptides, and its deficiency leads to accumulation of proline-containing dipeptides, causing toxicity.
Diabetic Nephropathy and Carnosine Metabolism
CNDP1 polymorphisms have been associated with susceptibility to diabetic nephropathy. Carnosine, a dipeptide with antioxidant properties, is hydrolyzed by CNDP1 and CNDP2. Altered dipeptidase activity may affect carnosine levels, contributing to oxidative stress and kidney damage in diabetes.
Cancer
DPEP1 is overexpressed in several cancers, including colorectal and renal cell carcinoma, and its dipeptidase activity may promote tumor growth by modulating peptide hormones. CNDP2 is also implicated in cancer metabolism, with its metal-dependent substrate specificity potentially influencing tumor progression.
Neurological Disorders
Carnosine and its dipeptidases are involved in neuroprotection. Dysregulation of CNDP1 and CNDP2 may contribute to neurodegenerative diseases such as Alzheimer's and Parkinson's, where carnosine levels are altered.
From dipeptidase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CNDP1 affect carnosine levels? | CNDP1 knockout cell line (e.g., HEK293) |
| How does the zinc/manganese switch alter CNDP2 substrate specificity? | Point mutation of metal-binding residues in CNDP2 |
| Can DPEP1 hydrolyze beta-lactam antibiotics? | DPEP1 knock-in in bacteria; enzymatic assays |
| What is the role of prolidase in wound healing? | PEPD knockout mouse; skin fibroblasts |
| Does C69 dipeptidase require cysteine for catalysis? | Cysteine-to-alanine point mutation |
| Can immobilized dipeptidase synthesize carnosine? | Overexpression and immobilization on nanocrystals |
How to Study the dipeptidase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Colorimetric activity assay | Dipeptidase enzymatic activity | Screening for inhibitors |
| CRISPR-Cas9 knockout | Gene function | Loss-of-function studies |
| Site-directed mutagenesis | Role of specific residues | Mechanistic studies |
| Mass spectrometry | Peptide and metabolite levels | Metabolomics |
| X-ray crystallography | 3D structure | Active site analysis |
| Western blotting | Protein expression | Knockout validation |
| qRT-PCR | mRNA levels | Gene expression analysis |
| Enzyme kinetics | Km, Vmax, kcat | Substrate specificity |
Enzymatic Activity Assays
Dipeptidase activity is typically measured using colorimetric or fluorogenic substrates. For example, hydrolysis of Gly-Pro-p-nitroanilide can be monitored spectrophotometrically. Metal chelators and specific inhibitors are used to determine cofactor requirements.
CRISPR-Cas9 Knockout Studies
CRISPR-Cas9 knockout of dipeptidase genes in cell lines allows assessment of their contribution to peptide metabolism, cell growth, and stress responses. Knockout models can be validated by western blotting and activity assays.
Proteomics and Metabolomics
Mass spectrometry-based proteomics and metabolomics can quantify dipeptidase expression and substrate/product levels. This approach is useful for identifying novel dipeptidase substrates and pathways.
Structural Biology
X-ray crystallography and cryo-EM provide insights into the active site architecture and metal coordination of dipeptidases. Such studies guide the design of specific inhibitors.
How CRISPR Can Be Used to Study GO:0016805 dipeptidase activity
Knockout
CRISPR-Cas9 knockout of dipeptidase genes (e.g., CNDP1, CNDP2, PEPD) in cell lines or animal models enables the study of their physiological roles. For example, CNDP1 knockout cells show altered carnosine levels and increased oxidative stress. Knockout models are also used to validate drug targets.
Point Mutation
Point mutations can be introduced to dissect catalytic mechanisms. For instance, mutating the metal-binding residues in CNDP2 can switch its cofactor preference and substrate specificity. Similarly, mutating the active site cysteine in C69-family dipeptidases abolishes activity.
Knock-in
Knock-in of tagged dipeptidases (e.g., GFP or FLAG) allows real-time imaging and pull-down assays. Knock-in of disease-associated mutations (e.g., PEPD mutations) can model prolidase deficiency in cells.
Overexpression
Overexpression of dipeptidases in bacterial or mammalian cells is used for enzyme purification, structural studies, and biotechnological applications such as carnosine synthesis. Overexpression can also reveal gain-of-function phenotypes in cancer models.
How EDITGENE Supports dipeptidase activity Research
Researchers studying dipeptidase activity-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. This requires precise genetic manipulation, which can be achieved through CRISPR-based knockout, point mutation, knock-in, or overexpression models. EDITGENE provides comprehensive services to support such studies, from cell line generation to library screening and bioinformatics analysis.
Contact EDITGENE today to design your custom CRISPR model for dipeptidase activity research.
Frequently Asked Questions About dipeptidase activity
What is dipeptidase activity?
Dipeptidase activity (GO:0016805) is the catalysis of the hydrolysis of a dipeptide into two amino acids. It is a molecular function essential for protein digestion and peptide recycling.
What genes are involved in dipeptidase activity?
Key genes include CNDP1, CNDP2, PEPD, DPEP1, and LAP3, each encoding enzymes with distinct substrate specificities and tissue distributions.
What diseases are associated with dipeptidase deficiency?
Prolidase deficiency, caused by PEPD mutations, leads to skin ulcers and impaired wound healing. CNDP1 variants are linked to diabetic nephropathy.
How is dipeptidase activity measured?
It is measured using colorimetric or fluorogenic substrates, such as Gly-Pro-p-nitroanilide, in enzymatic assays.
What cofactors do dipeptidases require?
Many dipeptidases are metalloenzymes requiring zinc or manganese, while others are cysteine-dependent.
What is the role of carnosine dipeptidase?
Carnosine dipeptidases (CNDP1 and CNDP2) hydrolyze carnosine, regulating its antioxidant and anti-glycation effects.
Can dipeptidases be targeted for cancer therapy?
Yes, DPEP1 and CNDP2 are overexpressed in some cancers and are being explored as therapeutic targets.
How does CRISPR help study dipeptidase activity?
CRISPR knockout, point mutation, and knock-in models allow precise dissection of dipeptidase gene function in cells and animals.
What is the difference between dipeptidase and prolidase?
Prolidase (PEPD) is a specific dipeptidase that hydrolyzes dipeptides containing proline, while dipeptidases encompass a broader range of enzymes.
Where are dipeptidases located in the cell?
They are found in the cytosol, on the plasma membrane, and in some cases secreted, depending on the specific enzyme.
Conclusion
Dipeptidase activity (GO:0016805) is a fundamental molecular function that governs the final steps of protein catabolism and the metabolism of bioactive peptides. Its key enzymes, including CNDP1, CNDP2, PEPD, and DPEP1, play critical roles in human health and disease, from digestion and antioxidant defense to cancer and neurological disorders. Advances in CRISPR-based genetic models and analytical methods are enabling researchers to dissect the precise functions of these enzymes. EDITGENE provides a comprehensive suite of services to support such research, from custom knockout and knock-in cell lines to high-throughput screening and bioinformatics.
References
- 1. Boldyrev AA et al.. 2013. Physiology and pathophysiology of carnosine.. Physiol Rev 93(4):1803-45 PMID: 24137022
- 2. Namiduru ES. 2016. Prolidase.. Bratisl Lek Listy 117(8):480-5 PMID: 27546702
- 3. Rolls BA. 1975. Dipeptidase activity in the small intestinal mucosa during pregnancy and lactation in the rat.. Br J Nutr 33(1):1-9 PMID: 1115750
- 4. Campbell BJ et al.. 1984. Beta-lactamase activity of purified and partially characterized human renal dipeptidase.. J Biol Chem 259(23):14586-90 PMID: 6334084
- 5. Okumura N et al.. 2017. The zinc form of carnosine dipeptidase 2 (CN2) has dipeptidase activity but its substrate specificity is different from that of the manganese form.. Biochem Biophys Res Commun 494(3-4):484-490 PMID: 29056506
- 6. Liu Y et al.. 2024. Immobilized Dipeptidase in Manganese Ion-Loaded Polyethylenimine-Induced Calcium Phosphate Nanocrystals for Carnosine Synthesis.. Langmuir 40(19):10261-10269 PMID: 38693862
- 7. Sakamoto T et al.. 2013. A C69-family cysteine dipeptidase from Lactobacillus farciminis JCM1097 possesses strong Gly-Pro hydrolytic activity.. J Biochem 154(5):419-27 PMID: 23986487
- 8. Panpetch P et al.. 2021. Fruit ripening-associated leucylaminopeptidase with cysteinylglycine dipeptidase activity from durian suggests its involvement in glutathione recycling.. BMC Plant Biol 21(1):69 PMID: 33526024
